Affinity Asset Advisors, LLC Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$867.5T
Holdings
91
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (91 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TR | 350,000 | $190.5T | 21.96% | Put |
| 2 | TEVATEVA PHARMACEUTICAL INDS LTD | 2,600,000 | $42.3T | 4.87% | Call |
| 3 | XENEXENON PHARMACEUTICALS INC | 994,227 | $38.8T | 4.47% | |
| 4 | APGEAPOGEE THERAPEUTICS INC | 836,283 | $32.9T | 3.79% | |
| 5 | MDGLMADRIGAL PHARMACEUTICALS INC | 110,000 | $30.8T | 3.55% | |
| 6 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 750,000 | $30.7T | 3.54% | Call |
| 7 | ACLXARCELLX INC | 460,000 | $25.4T | 2.93% | |
| 8 | CRNXCRINETICS PHARMACEUTICALS IN | 515,000 | $23.1T | 2.66% | |
| 9 | NRIXNURIX THERAPEUTICS INC | 912,000 | $19.0T | 2.19% | |
| 10 | TCE2CELLDEX THERAPEUTICS INC NEW | 475,400 | $17.6T | 2.03% | |
| 11 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 17,000,000 | $17.3T | 1.99% | |
| 12 | ALNY 1 09/15/27ALNYLAM PHARMACEUTICALS INC | 15,000,000 | $16.2T | 1.87% | |
| 13 | ONCBEIGENE LTD | 110,000 | $15.7T | 1.81% | |
| 14 | ALKSALKERMES PLC | 650,000 | $15.7T | 1.81% | |
| 15 | NUVLNUVALENT INC | 200,000 | $15.2T | 1.75% | |
| 16 | AUTLAUTOLUS THERAPEUTICS PLC | 4,300,000 | $15.0T | 1.72% | |
| 17 | VERAVERA THERAPEUTICS INC | 375,000 | $13.6T | 1.56% | |
| 18 | KURAKURA ONCOLOGY INC | 650,000 | $13.4T | 1.54% | |
| 19 | INZYINOZYME PHARMA INC | 2,856,252 | $12.7T | 1.47% | |
| 20 | SYRESPYRE THERAPEUTICS INC | 513,420 | $12.1T | 1.39% | |
| 21 | CLYMELIEM THERAPEUTICS INC | 1,670,661 | $11.9T | 1.37% | |
| 22 | IMVTIMMUNOVANT INC | 400,388 | $10.6T | 1.22% | Call |
| 23 | CNTACENTESSA PHARMACEUTICALS PLC | 1,135,702 | $10.3T | 1.18% | |
| 24 | ESTAESTABLISHMENT LABS HLDGS INC | 223,407 | $10.2T | 1.17% | |
| 25 | VRNAVERONA PHARMA PLC | 700,000 | $10.1T | 1.17% | |
| 26 | NARIUSDINARI MED INC | 200,000 | $9.6T | 1.11% | |
| 27 | IM8NINSMED INC | 133,700 | $9.0T | 1.03% | Put |
| 28 | CATBUSDASTRIA THERAPEUTICS INC | 975,606 | $8.9T | 1.02% | |
| 29 | —COHERUS BIOSCIENCES INC | 11,750,000 | $8.6T | 1.00% | |
| 30 | MORFMORPHIC HLDG INC | 250,573 | $8.5T | 0.98% | |
| 31 | NAMSNEWAMSTERDAM PHARMA COMPANY | 423,155 | $8.1T | 0.94% | |
| 32 | OMER 5.25 02/15/26OMEROS CORP | 11,450,000 | $8.1T | 0.93% | |
| 33 | RZLTREZOLUTE INC | 1,850,000 | $8.0T | 0.92% | |
| 34 | MRUSMERUS N V | 125,000 | $7.4T | 0.85% | |
| 35 | AXSMAXSOME THERAPEUTICS INC | 80,000 | $6.4T | 0.74% | |
| 36 | GONGERON CORP | 1,500,000 | $6.4T | 0.73% | |
| 37 | KPTI 3 10/15/25KARYOPHARM THERAPEUTICS INC | 9,750,000 | $6.3T | 0.73% | |
| 38 | YB4PSAVARA INC | 1,546,850 | $6.2T | 0.72% | |
| 39 | ERASERASCA INC | 2,499,431 | $5.9T | 0.68% | |
| 40 | PCVXVAXCYTE INC | 75,000 | $5.7T | 0.65% | Call |
| 41 | CATXPERSPECTIVE THERAPEUTICS INC | 550,000 | $5.5T | 0.63% | |
| 42 | MIRMMIRUM PHARMACEUTICALS INC | 155,000 | $5.3T | 0.61% | |
| 43 | CGEMCULLINAN THERAPEUTICS INC | 263,817 | $4.6T | 0.53% | |
| 44 | —ELEVATION ONCOLOGY INC | 1,468,825 | $4.0T | 0.46% | |
| 45 | HLVXHILLEVAX INC | 265,859 | $3.8T | 0.44% | |
| 46 | MLYSMINERALYS THERAPEUTICS INC | 327,959 | $3.8T | 0.44% | |
| 47 | ROIVROIVANT SCIENCES LTD | 351,587 | $3.7T | 0.43% | |
| 48 | DYNDYNE THERAPEUTICS INC | 100,000 | $3.5T | 0.41% | |
| 49 | —PERCEPTIVE CAP SOLUTIONS COR | 350,000 | $3.5T | 0.41% | |
| 50 | IMTXIMMATICS N.V | 300,000 | $3.5T | 0.40% | |
| 51 | XBISPDR SER TR | 37,550 | $3.5T | 0.40% | |
| 52 | CNTXCONTEXT THERAPEUTICS INC | 1,619,140 | $3.2T | 0.37% | |
| 53 | BDTXBLACK DIAMOND THERAPEUTICS I | 650,000 | $3.0T | 0.35% | |
| 54 | CMPSCOMPASS PATHWAYS PLC | 500,512 | $3.0T | 0.35% | |
| 55 | OLMAOLEMA PHARMACEUTICALS INC | 275,000 | $3.0T | 0.34% | |
| 56 | SANASANA BIOTECHNOLOGY INC | 521,000 | $2.8T | 0.33% | Put |
| 57 | NXTCNEXTCURE INC | 1,687,955 | $2.7T | 0.31% | |
| 58 | SWTXSPRINGWORKS THERAPEUTICS INC | 69,999 | $2.6T | 0.30% | |
| 59 | HLXCHELIX ACQUISITION CORP II | 250,000 | $2.6T | 0.29% | |
| 60 | BBIOBRIDGEBIO PHARMA INC | 100,000 | $2.5T | 0.29% | |
| 61 | TWSTTWIST BIOSCIENCE CORP | 45,000 | $2.2T | 0.26% | Call |
| 62 | VRDNVIRIDIAN THERAPEUTICS INC | 150,000 | $2.0T | 0.22% | |
| 63 | NAMSNEWAMSTERDAM PHARMA COMPANY | 202,599 | $1.9T | 0.22% | |
| 64 | RAPTEURRAPT THERAPEUTICS INC | 620,000 | $1.9T | 0.22% | Put |
| 65 | WVEWAVE LIFE SCIENCES LTD | 375,000 | $1.9T | 0.22% | |
| 66 | VIRVIR BIOTECHNOLOGY INC | 200,000 | $1.8T | 0.21% | |
| 67 | ZYMEZYMEWORKS INC | 191,127 | $1.6T | 0.19% | |
| 68 | FULCFULCRUM THERAPEUTICS INC | 250,000 | $1.6T | 0.18% | Call |
| 69 | —MERSANA THERAPEUTICS INC | 767,000 | $1.5T | 0.18% | |
| 70 | —ARYA SCIENCES ACQU CORP IV | 133,500 | $1.5T | 0.18% | |
| 71 | ADCTADC THERAPEUTICS SA | 474,744 | $1.5T | 0.17% | |
| 72 | KYTXKYVERNA THERAPEUTICS INC | 200,000 | $1.5T | 0.17% | |
| 73 | ARWRARROWHEAD PHARMACEUTICALS IN | 50,000 | $1.3T | 0.15% | |
| 74 | TNGXTANGO THERAPEUTICS INC | 150,274 | $1.3T | 0.15% | |
| 75 | IOVAIOVANCE BIOTHERAPEUTICS INC | 150,100 | $1.2T | 0.14% | Put |
| 76 | NKTXNKARTA INC | 200,000 | $1.2T | 0.14% | |
| 77 | KZRKEZAR LIFE SCIENCES INC | 1,761,778 | $1.1T | 0.12% | |
| 78 | TECXTECTONIC THERAPEUTIC INC | 58,331 | $960.7B | 0.11% | |
| 79 | PBYIPUMA BIOTECHNOLOGY INC | 250,000 | $815.0B | 0.09% | |
| 80 | ZURAZURA BIO LTD | 223,335 | $781.7B | 0.09% | |
| 81 | ALXOALX ONCOLOGY HLDGS INC | 100,000 | $603.0B | 0.07% | Call |
| 82 | AVTXAVALO THERAPEUTICS INC | 45,000 | $561.1B | 0.06% | |
| 83 | QTTBQ32 BIO INC | 27,777 | $498.6B | 0.06% | |
| 84 | IMTXIMMATICS N.V | 187,204 | $484.9B | 0.06% | |
| 85 | MTVANEUROBO PHARMACEUTICALS IN | 89,222 | $431.8B | 0.05% | |
| 86 | PMNEURPROMIS NEUROSCIENCES INC | 265,958 | $398.9B | 0.05% | |
| 87 | AVTEAEROVATE THERAPEUTICS INC | 200,000 | $332.0B | 0.04% | |
| 88 | ABIOEURARCA BIOPHARMA INC | 72,484 | $277.6B | 0.03% | |
| 89 | PASGPASSAGE BIO INC | 264,266 | $209.9B | 0.02% | |
| 90 | GNLXGENELUX CORPORATION | 100,000 | $195.0B | 0.02% | |
| 91 | RCKTWROCKET PHARMACEUTICALS INC | 75,000 | $4.5B | 0.00% |